Nimodipine Reduces Dysfunction and Demyelination in Models of Multiple Sclerosis

OBJECTIVE: Treatment of relapses in multiple sclerosis (MS) has not advanced beyond steroid use, which reduces acute loss of function, but has little effect on residual disability. Acute loss of function in an MS model (experimental autoimmune encephalomyelitis [EAE]) is partly due to central nervou...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Ann Neurol
Main Authors: Desai, Roshni A., Davies, Andrew L., Del Rossi, Natalie, Tachrount, Mohamed, Dyson, Alex, Gustavson, Britta, Kaynezhad, Pardis, Mackenzie, Lewis, van der Putten, Marieke A., McElroy, Daniel, Schiza, Dimitra, Linington, Christopher, Singer, Mervyn, Harvey, Andrew R., Tachtsidis, Ilias, Golay, Xavier, Smith, Kenneth J.
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley & Sons, Inc. 2020
נושאים:
Research Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7737229/
https://ncbi.nlm.nih.gov/pubmed/32293054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25749
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים